Area of research
Epidemiology · Hepatology
Research interest
Research interests include Hepatocellular carcinoma, Medicine, Cancer research, Hepatitis B virus, Internal medicine, and Biology.
DC-SIGN+ macrophages alleviate metabolic dysfunction-associated steatotic liver disease via fine-tuning TLR4 signaling and inflammatory secretory profiles
Research progress in molecular targeted therapy for inflammatory bowel disease
The upregulation of Annexin A2 by TLR4 pathway facilitates lipid accumulation and liver injury via blocking AMPK/mTOR-mediated autophagy flux during the development of non-alcoholic fatty liver disease
Clinical features of upper gastrointestinal endoscopy in 3146 patients: a 9-year retrospective cohort study in Zanzibar Archipelago, Tanzania
Identifying a locus in super-enhancer and its resident NFE2L1/MAFG as transcriptional factors that drive PD-L1 expression and immune evasion
Clinical characteristics of colonoscopy in 448 patients in the Zanzibar Archipelago: a cross-sectional study
MCCC2 promotes HCC development by supporting leucine oncogenic function
USP7 mediates pathological hepatic de novo lipogenesis through promoting stabilization and transcription of ZNF638
A novel β2-AR/YB-1/β-catenin axis mediates chronic stress-associated metastasis in hepatocellular carcinoma
Ubiquitin-specific protease 7 is a drug-able target that promotes hepatocellular carcinoma and chemoresistance
Identification of prognostic risk factors for pancreatic cancer using bioinformatics analysis
HPV shapes tumor transcriptome by globally modifying the pool of RNA binding protein-binding motif
High expression of Anxa2 and Stat3 promote progression of hepatocellular carcinoma and predict poor prognosis
Identification of cancer-related gene network in hepatocellular carcinoma by combined bioinformatic approach and experimental validation
Effects of TACE and preventive antiviral therapy on HBV reactivation and subsequent hepatitis in hepatocellular carcinoma: a meta-analysis
MKP-4 suppresses hepatocarcinogenesis by targeting ERK1/2 pathway
Progress of Exosomes in the Diagnosis and Treatment of Pancreatic Cancer
Nucleostemin promotes hepatocellular carcinoma by regulating the function of STAT3
A Comparison of Traditional and Novel Methods for the Separation of Exosomes from Human Samples
β2-AR regulates the expression of AKR1B1 in human pancreatic cancer cells and promotes their proliferation via the ERK1/2 pathway
Coupling function of cyclin‐dependent kinase 2 and Septin2 in the promotion of hepatocellular carcinoma
ARP3 promotes tumor metastasis and predicts a poor prognosis in hepatocellular carcinoma
Pre-S deletions of hepatitis B virus predict recurrence of hepatocellular carcinoma after curative resection
Risk Factors for Prognosis of Hepatocellular Carcinoma After Curative Resection In Patients with Low Hepatitis B Viral Load
Risk Factors for Prognosis of Hepatocellular Carcinoma After Curative Resection In Patients with Low Hepatitis B Viral Load.
Overexpression of DLX2 is associated with poor prognosis and sorafenib resistance in hepatocellular carcinoma
Therapeutic effects of triptolide via the inhibition of IL-1β expression in a mouse model of ulcerative colitis
Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma
Nuclear transcription factor CDX2 inhibits gastric cancer-cell growth and reverses epithelial-to-mesenchymal transition in vitro and in vivo
Nine susceptibility loci for hepatitis B virus-related hepatocellular carcinoma identified by a pilot two-stage genome-wide association study